Pathways analysis revealed that CAVD patients without CHIP in comparison with non-calcific controls show disruption in multiple pathways including, Th1, Th2, and NK cell signaling, leukocytes extravasation, phagosome activation, atherosclerosis signaling, and inhibition of matrix metalloproteases (Fig. 3a, right panel). Here, STUB1 is linked to atherosclerosis.